About Deciphera

Deciphera Pharmaceuticals was established in 2003 as a drug research and development company. Our mission is to design, optimize and introduce "best-in-class" small molecule switch pocket inhibitors of protein kinases for human clinical trials and the global pharmaceutical marketplace. In 2012, Deciphera transitioned to an oncology development company, focusing its efforts on the clinical evaluation of its oncology pipeline.